Regulatory News
Thursday, December 8, 2016
BRIEF-Biogen presents data from Phase 1b study of investigational Alzheimer's Disease Treatment at 2016 clinical trials on Alzheimer's Disease Meeting
* Biogen presents data from Phase 1b study of
investigational Alzheimer's disease treatment Aducanumab at 2016
clinical trials on Alzheimer's Disease Meeting
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment